Toggle menu

ROSE

Start date:
Historic
End date:
Jan 2009
Co-ordinated by:
NHS Lothian

Risk Stratification Of Syncope in the Emergency department

Aim

To develop and validate a Clinical Decision Rule using history, examination, electrocardiographic and biochemical markers, to predict one month outcome for patients presenting with syncope to the Emergency Department

Trial Design

Single-centre, prospective, observational cohort study,  conducted in the Emergency Department (ED) of the Royal Infirmary of Edinburgh.

List of Publications – references

  • Reed MJ, Newby DE, Coull AJ, Jacques KG, Prescott RJ, Gray AJ. Risk stratification Of Syncope in the Emergency department: The ROSE study. JACC 2010: 55(8); 713-721. PMID: 20170806
  • Reed MJ, Mills NL, Weir CJ. Sensitive troponin assay predicts outcome in syncope. Emerg Med J. 2012; 29(12): 1001-3. PMID: 22962048
  • Reed MJ, Henderson SS, Newby DE, Gray AJ. One-year prognosis after syncope and the failure of the ROSE decision instrument to predict 1 year adverse events. Annals of Emergency Medicine 2011; DOI: 10.1016/j.annemergmed.2010.12.021. PMID: 21288597
  • Sun BC, Costantino G, Barbic F, Bossi I, Casazza G, Dipaola F, McDermott F, Quinn J, Reed MJ, Sheldon RS, Solbiati M, Thiruganasambandamoorthy V, Krahn AD, Beach D, Bodemer N, Brignole M, Casagranda I, Duca P, Falavigna G, Ippoliti R, Montano N, Olshansky B, Raj SR, Ruwald MH, Shen W-K, Stiell I, Ungar A, van Dijk JG, van Dijk N, Wieling W, Furlan R. Priorities for Emergency Department Syncope Research. Published ahead of print Annals of Emergency Medicine May 29, 2014. DOI: http://dx.doi.org/10.1016/j.annemergmed.2014.04.014. PMID: 24882667
  • Sun BC, Thiruganasambandamoorthy V, Dela Cruz J, Abe H, Barbic F, Blanc J-J, Colivicchi F, Dipaola F, Furlan R,Costantino G, Grossman S, Hess E, Krahn A, Lipsitz L, Morillo C, Olshansky B, Quinn J, Raviele A, Reed MJ, Sarasin F, Satish R, Serrano L, Sheldon R, Thijs R, Ungar A, van Dijk G, van Dijk N. Standardized Reporting Guidelines for Emergency Department Syncope Risk Stratification Research. Accepted by Academic Emergency Medicine.

Chief Investigator

Dr Matt Reed

Director of EMERGE, Consultant, NRS Career Research Fellow & Honorary Reader in Emergency Medicine

Local PI

Dr Matt Reed

Director of EMERGE, Consultant, NRS Career Research Fellow & Honorary Reader in Emergency Medicine

More EMERGE Trials

The purpose of this study is to test a new vaccine, ChAdOx1 nCoV-19, against COVID-19 in healthy volunteers.

The ChAdOx1 nCoV-19 vaccine has been developed in Oxford in an effort to protect healthy people from the pandemic. This study will evaluate the safety of the vaccine and its ability to generate an immune response against the virus.  

This is a randomised trial. Participants will be randomly allocated to receive either the ChAdOx1 nCoV-19 vaccine, or a Men ACWY (meningitus vaccine). Volunteers will not be told which vaccine they will receive.

Participants will be asked to return for 6 visits across 12 months to evaluate their health.

Across the UK the trial aims to recruit 10,260 volunteers.

If you are interested in taking part, please click on this link and complete the online questionnaire: https://www.covid19vaccinetrial.co.uk/participate-edinburgh

Read more

COV_002 Vaccine Trial

The purpose of this study is to test a new vaccine against COVID-19 in healthy volunteers.

PRIEST

Pandemic Respiratory Infection Emergency System Triage